This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57617796
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в січні 2007 scientific article published on 23 October 2006 artículu científicu espublizáu n'ochobre de 2006 wetenschappelijk artikel im Januar 2007 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q57617796-385D0E87-2DAF-4D0A-B367-CF7BBAD24D31
wdt:P577
2006-10-23T00:00:00Z
p:P407
wds:Q57617796-8C70B245-D703-4A11-BCA3-5496AD976CEA
wdt:P407
wd:Q1860
p:P2093
wds:Q57617796-8F0704CD-8053-4B68-8BD1-9F1F0FB819E2 wds:Q57617796-FDF42832-058D-43A2-9564-38ED2931FDF9 wds:Q57617796-66D550E2-7914-4286-B780-D76D95DB722B wds:Q57617796-E616DBC4-CC84-4582-B0BF-4C770B69FA6E wds:Q57617796-87052ADA-FEFC-45E4-B43E-2ED74D5733C3 wds:Q57617796-75217759-F255-4E18-865E-09C7B8CBCC45 wds:Q57617796-200F68F5-D884-48B4-8C0A-F57845365056 wds:Q57617796-0F0F9086-274B-412B-B619-79792E77798E
wdt:P2093
Lee Manchul Wilfred Levin Melania Pintilie Fernanda G Herrera Amit Oza Philip Chan Amy Syed Corinne Doll
rdfs:label
A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment
skos:prefLabel
A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment
schema:name
A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment
p:P50
wds:Q57617796-33B038F1-A6C0-4068-862B-80806F97EF2D wds:Q57617796-44BD0720-D1BF-49CB-849F-0F407E5FAA23
wdt:P50
wd:Q38802704 wd:Q43490969
p:P1476
wds:Q57617796-28983C81-8A53-4A2E-BE25-5887802DBDE8
wdt:P1476
A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment
p:P304
wds:Q57617796-2FFFC8F1-01DD-48B8-8EED-2DF69E14ED63
wdt:P304
97-103
p:P31
wds:Q57617796-740DA94F-717D-45B4-8F60-7B522AB35EF1
wdt:P31
wd:Q13442814
p:P921
wds:Q57617796-5750C38B-F3F6-4478-8AA2-BE8952BF95B8 wds:Q57617796-C3ED76DC-D6CC-4156-A67A-B6E2A4FF8EE3 wds:Q57617796-E156941E-9FE3-410C-AC51-B259BF1D75BE
wdt:P921
wd:Q5452194 wd:Q864574 wd:Q181600
p:P698
wds:Q57617796-0FCD72BE-4526-4556-A5E5-506DA919C306
wdtn:P698
n12:17056201
wdt:P698
17056201
p:P1433
wds:Q57617796-79701186-7A80-4A52-B135-BC06D6EE5BAD
wdt:P1433
wd:Q2296252
p:P433
wds:Q57617796-2F9224C3-A66F-41E8-B635-95AB62088A96
p:P478
wds:Q57617796-E02F0E73-8D09-49C0-9BFA-B684CC1EB10F
wdt:P433
1
wdt:P478
67
p:P356
wds:Q57617796-C77502E8-3A40-4C0E-8B24-52B68F770BCA
wdtn:P356
n10:J.IJROBP.2006.08.024
wdt:P356
10.1016/J.IJROBP.2006.08.024